mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.4 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.4 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
-0.039 |
0.4 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.4 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |